PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Aflibercept (Eylea)- FDA 14 Drug Disease Glioblastoma 17,933 1 0.00 -0.96 0.07 0.62
Amifostine (Ethyol)- FDA 14 Drug Disease Lung Cancer 91,416 3 0.00 -0.89 0.21 0.60
Meningitis Bacterial 14 Disease Disease Bacterial Infections 14,248 1 0.00 -0.96 0.07 0.62
Atropine (Atropine)- FDA 13 Drug Disease Poisoning 53,779 5 0.01 -0.78 0.38 0.63
Atropine (Atropine)- FDA 13 Drug Disease Depression 220,092 1 0.00 -0.96 0.08 0.56
Atropine (Atropine)- FDA 13 Drug Disease Nausea 42,627 1 0.00 -0.96 0.08 0.60
Atropine (Atropine)- FDA 13 Drug Disease Coma 24,208 1 0.00 -0.96 0.08 0.61
Atropine (Atropine)- FDA 13 Drug Disease Hypotension 42,123 1 0.00 -0.96 0.08 0.60
Atropine (Atropine)- FDA 13 Drug Disease Cardiac Arrest 20,700 1 0.00 -0.96 0.08 0.61
Atropine (Atropine)- FDA 13 Drug Disease Amyotrophic Lateral Sclerosis 14,006 1 0.00 -0.96 0.08 0.62
Atropine (Atropine)- FDA 13 Drug Disease Dysmenorrhea 3,263 1 0.00 -0.96 0.08 0.66
Atropine (Atropine)- FDA 13 Drug Disease Muscle Weakness 9,178 1 0.00 -0.96 0.08 0.63
Atropine (Atropine)- FDA 13 Drug Disease Seizures 66,465 1 0.00 -0.96 0.08 0.59
Alpha (Prolastin)- FDA 13 Drug Disease Back Pain 30,003 1 0.00 -0.96 0.08 0.61
Alpha (Prolastin)- FDA 13 Drug Disease Chronic Obstructive Pulmonary Disease 27,780 3 0.00 -0.88 0.23 0.63
Alpha (Prolastin)- FDA 13 Drug Disease Infection 766,637 1 0.00 -0.96 0.08 0.54
Alpha (Prolastin)- FDA 13 Drug Disease Hepatitis B 57,815 1 0.00 -0.96 0.08 0.59
Alpha (Prolastin)- FDA 13 Drug Disease Cholesterol 182,390 1 0.00 -0.96 0.08 0.57
Alpha (Prolastin)- FDA 13 Drug Disease Hepatitis 163,842 1 0.00 -0.96 0.08 0.57
Alpha (Prolastin)- FDA 13 Drug Disease Pain 409,851 1 0.00 -0.96 0.08 0.55
Alpha (Prolastin)- FDA 13 Drug Disease Leukemia 162,805 1 0.00 -0.96 0.08 0.57
Alpha (Prolastin)- FDA 13 Drug Disease Heart Disease 118,291 1 0.00 -0.96 0.08 0.58
Nephropathy Diabetic 13 Disease Disease Albuminuria 6,831 2 0.01 -0.92 0.15 0.66
Nephropathy Diabetic 13 Disease Disease Hyperglycemia 28,168 1 0.00 -0.96 0.08 0.61
Nephropathy Diabetic 13 Disease Disease Glomerulonephritis 23,459 1 0.00 -0.96 0.08 0.61
Nephropathy Diabetic 13 Disease Disease Diabetic Nephropathy 12,496 11 0.03 -0.39 0.85 0.69
Nephropathy Diabetic 13 Disease Disease Anemia 81,663 1 0.00 -0.96 0.08 0.58
Nephropathy Diabetic 13 Disease Disease Hypotension 42,123 1 0.00 -0.96 0.08 0.60
Nephropathy Diabetic 13 Disease Disease Cholesterol 182,390 1 0.00 -0.96 0.08 0.57
Nephropathy Diabetic 13 Disease Disease Diabetic Retinopathy 14,494 2 0.00 -0.92 0.15 0.64
Nephropathy Diabetic 13 Disease Disease Hyperlipidemia 15,317 1 0.00 -0.96 0.08 0.62
Nephropathy Diabetic 13 Disease Disease Proteinuria 28,803 2 0.00 -0.92 0.15 0.62
Sulfonylurea Receptor 2b 13 Target Disease Stroke 146,992 1 0.00 -0.96 0.08 0.57
Sulfonylurea Receptor 2b 13 Target Disease Inflammation 252,734 1 0.00 -0.96 0.08 0.56
Sulfonylurea Receptor 2b 13 Target Disease Liver Disease 49,817 1 0.00 -0.96 0.08 0.59
Acitretin (Soriatane)- FDA 13 Drug Disease Rheumatoid Arthritis 78,952 2 0.00 -0.92 0.15 0.60
Acitretin (Soriatane)- FDA 13 Drug Disease Necrobiosis Lipoidica 623 1 0.01 -0.96 0.08 0.71
Acitretin (Soriatane)- FDA 13 Drug Disease Psoriasis 26,882 9 0.02 -0.55 0.69 0.66
Acitretin (Soriatane)- FDA 13 Drug Disease Brain Tumors 16,749 1 0.00 -0.96 0.08 0.62
Acitretin (Soriatane)- FDA 13 Drug Disease Ankylosing Spondylitis 9,665 1 0.00 -0.96 0.08 0.63
ATF-2 Protein 13 Target Disease Inflammation 252,734 1 0.00 -0.96 0.08 0.56
Tachykinin Receptor 1 13 Target Disease Inflammation 252,734 1 0.00 -0.96 0.08 0.56
Tachykinin Receptor 1 13 Target Disease Anxiety Disorder 8,985 1 0.00 -0.96 0.08 0.64
Tachykinin Receptor 1 13 Target Disease Dyslexia 3,832 1 0.00 -0.96 0.08 0.66
Abanoquil 12 Drug Disease Benign Prostatic Hyperplasia 10,026 1 0.00 -0.96 0.08 0.63
Abanoquil 12 Drug Disease Hypotension 42,123 1 0.00 -0.96 0.08 0.60
Leprosy Lepromatous 12 Disease Disease Inflammation 252,734 1 0.00 -0.96 0.08 0.56
ACAD8 11 Target Disease Prostate Cancer 71,064 1 0.00 -0.95 0.09 0.59
ACAD8 11 Target Disease Dehydration 21,928 1 0.00 -0.95 0.09 0.62
ACAD8 11 Target Disease Anemia 81,663 1 0.00 -0.95 0.09 0.59